| Autor: |
Chowdhury I; Dr Indira Chowdhury, Medical Officer, National Institute Of Neuroscience and Hospital, Dhaka, Bangladesh; E-mail: indirachy89@gmail.com., Mishu FA, Yasmin R, Begum K, Chanda PK, Alam MM, Mollah FH |
| Jazyk: |
angličtina |
| Zdroj: |
Mymensingh medical journal : MMJ [Mymensingh Med J] 2024 Jan; Vol. 33 (1), pp. 229-233. |
| Abstrakt: |
The aim of the study was to evaluate the quantities difference and persistence of antibody in home and hospital treated patients at different interval. A cross-sectional study was conducted in the Department of Biochemistry and Molecular Biology, BIRDEM General Hospital, from July, 2020 to June, 2021. This study protocol was approved by Institutional Review Board (IRB), BIRDEM. SARS-CoV-2 caused death of huge number of people. The disease most commonly represents with fever, cough, loss of smell sensation, fatigue etc. Who had mild symptoms did not admit at hospital. But when the disease progress to respiratory distress, involvement of lung field more than 50.0% and other complications then the patients need hospital admission. Hospital treated patients showed higher antibody status in comparison to home treated patients. Moreover it was reported that increased amount of antibody developed after 3rd and 4th months of SARS-CoV-2 infection. In this study, statistically significant difference of decaying antibody level between home and hospital treated patients was observed. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
